Collegium, BioDelivery To Combine Pain Portfolios In Proposed Merger

 
• By Joseph Haas

Collegium has offered a 54% share premium to acquire competitor BioDelivery, in an offer approved by both firm’s boards. The $604m price tag would double the size of Collegium’s product portfolio.

Two businessmen shaking hands during a meeting in the office, success, dealing, greeting & business partner concepts - soft light.
Collegium and BioDelivery have agreed to a merger joining their pain medication portfolios

More from Deals

More from Business